Dermpath Diagnostics, a fully owned subsidiary of Quest Diagnostics, is exclusively focused on providing exceptional Dermatopathology services and is backed by an unrivaled team of over 70 board-certified Dermatopathologists, advanced diagnostic technologies and unparalleled clinician/patient support.
Our mission is to provide accurate, clear and prompt diagnoses. We also strive to develop confident relationships with our referring clinicians and are fully committed to assisting in providing the best care for every patient.
Dermpath Diagnostics – Pompano Beach, FL is currently seeking two board-certified Dermatopathologists to join our practice. These key positions will offer the practice of full-time Dermatopathology and will work with 11 experienced Dermatopathologists in a supportive, congenial atmosphere where being a team-player is imperative.
Pompano Beach, FL is known as the Heart of the Gold Coast. The city combines relaxed beach town charm with easy access to top-tier dining, shopping, and entertainment in nearby Fort Lauderdale and Miami.
Dermpath Diagnostics offers a comprehensive and competitive benefits package which includes paid time off, Medical, Dental, Prescription, Vision, Life and AD&D, STD, LTD, Supplemental Benefits and 401(k) with company contribution after 1 year of service.
Alicia.M.Baldon@QuestDiagnostics.com
Executive Medical Recruiting Consultant
60636
Quest Diagnostics honors our service members and encourages veterans to apply.
While we appreciate and value our staffing partners, we do not accept unsolicited resumes from agencies. Quest will not be responsible for paying agency fees for any individual as to whom an agency has sent an unsolicited resume.
Equal Opportunity Employer: Race/Color/Sex/Sexual Orientation/Gender Identity/Religion/National Origin/Disability/Vets or any other legally protected status.

Quest Diagnostics (NYSE: DGX) empowers people to take action to improve health outcomes. Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve health care management. Quest annually serves one in three adult Americans and half the physicians and hospitals in the United States, and our 47,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives.
The company offers physicians the broadest test menu (3,000+ tests), is a pioneer in developing innovative new tests, is the leader in cancer diagnostics, provides anatomic pathology (AP) services, & interpretive consultation through its medical & scientific staff of about 900 M.D.s & Ph.D.s. The company reported 2020 revenues of $9.44 billion.
Quest Diagnostics offers the most extensive clinical testing network in the U.S., with laboratories in most major metropolitan areas, & in Mexico, the UK & India. The company also operates four esoteric laboratories, 40 outpatient AP laboratories, & 160 smaller, rapid-response laboratories.
Patients may have specimens collected in any of the company’s approximately 2,250 patient service centers. On a typical workday, testing is performed for about 550,000 patients.
Quest Diagnostics empowers healthcare organizations & clinicians with state-of-the-art connectivity solutions.
The company is the leading provider of pre-employment drugs-of-abuse screening for employers & risk assessment services for the life insurance industry. It is the world’s 2nd largest provider of clinical trials testing for new pharmaceuticals.
More information is available at www.questdiagnostics.com.
Language Assistance / Non-Discrimination Notice
Asistencia de Idiomas / Aviso de no Discriminación
語言協助 / 不歧視通知
www.QuestDiagnostics.com/home/nondiscrimination